Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled versus autoinjector epinephrine for infant food-provocation anaphylaxis
2014-000097-19Phase 2Terminated
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jan 2016
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of epinephrine in anaphylaxis and food allergy (2 arms), sponsored by Charité – Universitätsmedizin Berlin. Started Jan 2016; status: terminated.
02
Drugs
epinephrine
03
Conditions
anaphylaxisfood allergy
Beyond the preview
Go deeper on 2014-000097-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000097-19.